Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for BCRX stock. Download BCRX report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download BCRX report
  
Example preview: Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX)
   

Income Statement for Biocryst Pharm, Inc (BCRX)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol:  | Recent Quotes powered by
  quotemedia.com
Income Statement for Biocryst Pharmaceuticals Inc.  (BCRX) 
$ 9.55   -0.85 (-8.17%) Volume: 6.75 m 4:00 PM EST Nov 20, 2009
After Hours:  $ 9.53   -0.02 (-0.21%) Volume: 43.0 k 7:54 PM EST Nov 20, 2009
Statement: View:
Income in Thousands of Dollars
12/2008 12/2007 12/2006 12/2005 12/2004
Operating Revenue 56,561 71,238 6,212 152 337
Adjustments to Revenue - - - - -
Cost of Revenue 1,626 1,370 821 865 969
Gross Operating Profit 58,187 72,608 7,033 1,016 1,306
Selling/General/Admin Expense (10,399) (9,466) (6,108) (3,686) (3,212)
Research & Development (73,327) (94,052) (47,083) (23,642) (18,868)
EBITDA (25,539) (30,910) (46,159) (26,312) (20,774)
Depreciation & Amortization (1,626) (1,370) (821) (865) (969)
EBIT (27,164) (32,280) (46,980) (27,177) (21,744)
Interest Income 2,433 3,225 3,362 1,078 648
Other Income, Net - - - - -
Total Income Avail For Interest Expense (24,732) (29,056) (43,618) (26,099) (21,104)
Interest Expense - - - - -
Pre-Tax Income (24,732) (29,056) (43,618) (26,099) (21,104)
Income Taxes - - - - -
Minority Interest - - - - -
Net Income from Continuing Operations (24,732) (29,056) (43,618) (26,099) (21,104)
Net Income from Discontinued Operations - - - - -
Net Income from Total Operations (24,732) (29,056) (43,618) (26,099) (21,104)
Normalized Income (24,732) (29,056) (43,618) (26,099) (21,096)
Extraordinary Income - - - - -
Special Income/Charges - - - - (8)
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Other Gains - - - - -
Total Net Income (24,732) (29,056) (43,618) (26,099) (21,104)
Results in Dollars (Preferred Dividends in Thousands)
12/2008 12/2007 12/2006 12/2005 12/2004
Dividends Paid Per Share 0.00 0.00 0.00 0.00 0.00
Preferred Dividends - - - - -
Basic EPS from Continuing Operations -0.65 -0.89 -1.50 -1.01 -1.00
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.65 -0.89 -1.50 -1.01 -1.00
Diluted EPS from Continuing Operations -0.65 -0.89 -1.50 -1.01 -1.00
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Operations -0.65 -0.89 -1.50 -1.01 -1.00

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Morningstar.  Terms of Use. 
   
 
Home > Companies > Biocryst Pharm, Inc